Company profile for JIANGSU VCARE PHARMATECH CO., LTD

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vcare is a chemistry-oriented pharmaceutical company focusing on research, production, ANDA and sales of generic drug. Vcare has built synthetic laboratories, analytical laboratories, and formulation laboratories. And we have built strategical cooperation with several manufacturers, which is a solid foundation for the industrialization and marketization of our projects.Since its inception, Vcare has developed rapidly. Currentl...
Vcare is a chemistry-oriented pharmaceutical company focusing on research, production, ANDA and sales of generic drug. Vcare has built synthetic laboratories, analytical laboratories, and formulation laboratories. And we have built strategical cooperation with several manufacturers, which is a solid foundation for the industrialization and marketization of our projects.Since its inception, Vcare has developed rapidly. Currently we have 70 employees, of whom 55 Researchers. In two years, Vcare has applied for 12 patents with licensed two and obtained 7 funds from government. At the same time, we have obtained line of credit more than 15 million RMB from the Bank.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
15 Wanshou Road, Pukou Economic Development Zone
Telephone
Telephone
86 255 874 1518
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/vcare-enters-into-exclusive-partnership-with-huadong-medicine-to-commercialize-its-second-generation-jak1-inhibitor-vc005-tablets-in-china-302530960.html

PR NEWSWIRE
15 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty